BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26134842)

  • 1. Hepatitis D Virus: Introduction and Epidemiology.
    Rizzetto M
    Cold Spring Harb Perspect Med; 2015 Jul; 5(7):a021576. PubMed ID: 26134842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hepatitis D.
    Rizzetto M; Ciancio A
    Semin Liver Dis; 2012 Aug; 32(3):211-9. PubMed ID: 22932969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adventure of delta.
    Rizzetto M
    Liver Int; 2016 Jan; 36 Suppl 1():135-40. PubMed ID: 26725911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis delta in HIV-infected individuals in Europe.
    Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
    AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The medical impact of hepatitis D virus infection in Uzbekistan.
    Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
    Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan.
    Hsieh MH; Wang SC; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2016 Oct; 32(10):526-530. PubMed ID: 27742037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
    Lin HH; Lee SS; Yu ML; Chang TT; Su CW; Hu BS; Chen YS; Huang CK; Lai CH; Lin JN; Wu JC
    Hepatology; 2015 Jun; 61(6):1870-9. PubMed ID: 25677884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline and changing profile of hepatitis delta among injection drug users in Spain.
    Aguilera A; Trastoy R; Barreiro P; Costa JJ; de Mendoza C; Peña JM; Soriano V
    Antivir Ther; 2018; 23(1):87-90. PubMed ID: 28353446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis D (DELTA).
    Rizzetto M
    New Microbiol; 2022 Jul; 45(3):149-154. PubMed ID: 35920869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
    Lu MY; Chen CT; Shih YL; Tsai PC; Hsieh MH; Huang CF; Yeh ML; Huang CI; Wang SC; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Yu ML; Chang WY
    Sci Rep; 2021 Apr; 11(1):8554. PubMed ID: 33879825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.
    Huang CR; Lo SJ
    World J Gastroenterol; 2014 Oct; 20(40):14589-97. PubMed ID: 25356023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The epidemiology and screening of hepatitis D].
    Xue F; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1017-1021. PubMed ID: 36727224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDV: thirty years later.
    Smedile A; Rizzetto M
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S15-8. PubMed ID: 21195366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis delta virus diagnosis.
    Olivero A; Smedile A
    Semin Liver Dis; 2012 Aug; 32(3):220-7. PubMed ID: 22932970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis D: clinical features and therapy.
    Rizzetto M
    Dig Dis; 2010; 28(1):139-43. PubMed ID: 20460902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.